一种NVL的小分子抑制剂通过阻断核糖体生物生成来抑制瘤生长
bioRxiv : the preprint server for biology
|August 6, 2025
概括
科学家们发现,抑制核糖体的产生,对于癌细胞生长至关重要,提供了一个新的向疗法. 使用像MM927这样的药物准NVL蛋白质在治疗白血病和结肠直肠癌中显示出有前途,毒性最小.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 药物发现 药物发现 药物发现
背景情况:
- 核糖体生物发生在癌细胞中受到上调,这可能会给癌细胞带来治疗上的脆弱性.
- 现有的化疗可以破坏核糖体的产生,但需要选择性抑制剂.
研究的目的:
- 在核糖体生物发生路径中识别新的治疗点.
- 为了研究MM17的作用机制,这是一种二索胺抗癌剂.
- 在临床前癌症模型中评估NVL抑制剂的治疗潜力.
主要方法:
- 转发遗传学选以识别对MM17的耐药性突变.
- 电子显微镜 (Cryo-EM) 用于确定NVL-MM17复合物的结构.
- 评估MM17对核糖体生物发生,细胞循环和亡的影响.
- 在白血病和结直肠癌的小鼠模型中进行MM927的临床前研究.
主要成果:
- 在60S核糖体子单元组装因子NVL中的突变赋予了对MM17的耐药性.
- 化EM检测显示,NVL上的MM17结合点与抗性突变相邻.
- MM17抑制了60S核糖体生物发生,诱导了p53依赖和独立的细胞死亡,没有DNA损伤.
- 同类型的MM927在体内抑制瘤生长的疗效被证明是有效的,没有观察到毒性.
结论:
- 在癌症治疗中,NVL是经过验证的标.
- 核糖体生物发生的抑制剂,如NVL抑制剂,代表了一类有前途的向治疗药物.
- 向核糖体生产利用癌症特异性的脆弱性进行有效的治疗.
相关概念视频
The Nucleolus
9.1K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.1K
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Types of RNA
64.9K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.9K
Ribosome Profiling
3.6K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.6K
Experimental RNAi
6.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Riboswitches
8.5K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.5K


